ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.4M |
7 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
21K
|
7.4M
|
7
|
|
ASX - By Stock
|
DXB Medicine |
Re:
DXB Media thread.
|
|
ma420
|
174 |
82K |
4 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
174
|
82K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
749K |
9 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
2.2K
|
749K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
537 |
183K |
4 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
537
|
183K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix and Taiba enter into License Agreement for DMX-200
|
|
ma420
|
152 |
62K |
5 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
152
|
62K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix and Taiba enter into License Agreement for DMX-200
|
|
ma420
|
152 |
62K |
5 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
152
|
62K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix and Taiba enter into License Agreement for DMX-200
|
|
ma420
|
152 |
62K |
9 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
152
|
62K
|
9
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix and Taiba enter into License Agreement for DMX-200
|
|
ma420
|
152 |
62K |
4 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
152
|
62K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity to present at ASCO and SNMMI 2023 Annual Meetings
|
|
ma420
|
10 |
6.1K |
5 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
10
|
6.1K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
ma420
|
126 |
30K |
7 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
126
|
30K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
3 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
227
|
97K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
2 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
227
|
97K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ma420
|
1.8K |
632K |
25 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
1.8K
|
632K
|
25
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
10 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
227
|
97K
|
10
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
8 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
227
|
97K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity to present at ASCO and SNMMI 2023 Annual Meetings
|
|
ma420
|
10 |
6.1K |
5 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
10
|
6.1K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
749K |
20 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
2.2K
|
749K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
749K |
18 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
2.2K
|
749K
|
18
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
5 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
227
|
97K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
749K |
2 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
2.2K
|
749K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
749K |
2 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
2.2K
|
749K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
9 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
227
|
97K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
20 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
227
|
97K
|
20
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
8 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
227
|
97K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
537 |
183K |
3 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
537
|
183K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
537 |
183K |
9 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
537
|
183K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Michael Kelso etc
|
|
ma420
|
12 |
3.7K |
1 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
12
|
3.7K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Dr Tillett - The Accidental Biotech CEO
|
|
ma420
|
7 |
3.1K |
1 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
7
|
3.1K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Dr Tillett - The Accidental Biotech CEO
|
|
ma420
|
7 |
3.1K |
13 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
7
|
3.1K
|
13
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.4M |
26 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
21K
|
7.4M
|
26
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
ma420
|
234 |
62K |
14 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
234
|
62K
|
14
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
537 |
183K |
16 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
537
|
183K
|
16
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
537 |
183K |
12 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
537
|
183K
|
12
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
3 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
227
|
97K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
1 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
227
|
97K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
749K |
9 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
2.2K
|
749K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
672 |
219K |
0 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
672
|
219K
|
0
|
|
ASX - By Stock
|
CVB |
Re:
CVB Media Links
|
|
ma420
|
9 |
4.6K |
0 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
9
|
4.6K
|
0
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
537 |
183K |
16 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
537
|
183K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust receives Orphan Drug Designation for monepantel
|
|
ma420
|
43 |
12K |
29 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
43
|
12K
|
29
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust receives Orphan Drug Designation for monepantel
|
|
ma420
|
43 |
12K |
17 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
43
|
12K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RAC Investor Presentation May 2024
|
|
ma420
|
55 |
15K |
8 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
55
|
15K
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.4M |
4 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
21K
|
7.4M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RAC Investor Presentation May 2024
|
|
ma420
|
55 |
15K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
55
|
15K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.4M |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
21K
|
7.4M
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ma420
|
615 |
188K |
4 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
615
|
188K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RAC Investor Presentation May 2024
|
|
ma420
|
55 |
15K |
26 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
55
|
15K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RAC Investor Presentation May 2024
|
|
ma420
|
55 |
15K |
7 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
55
|
15K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
ma420
|
104 |
31K |
4 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
104
|
31K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in CHM 0201 Vactosertib trial
|
|
ma420
|
16 |
8.2K |
5 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
16
|
8.2K
|
5
|
|